This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

152 Resources
152 Resources
152 Resources
    Date
  1. In 2020, Ghana switched from using ROTARIX® to ROTAVAC® in its national immunization program. PATH worked with Ghana Health Service and the University of Ghana to analyze the economic implications of this switch. These four fact sheets explore the key results of these analyses, collectively providing a case study on Ghana’s rotavirus vaccine product switch.(Manuscript pending submission to a peer-reviewed journal.)
    Published: May 2022
    Type: Resource Page
  2. The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization concluded that a single dose of human papillomavirus (HPV) vaccine delivers solid protection against HPV. Based on the available evidence, SAGE advised that countries may now choose between a one- or two-dose schedule for 9–14-year-old girls and women aged 15 to 20. This is a major step toward reaching the WHO’s global strategy to accelerate the elimination of cervical cancer.The following resource provides background on HPV and cervical cancer, HPV vaccines, and the current evidence and potential impact for a single-dose regimen.
    Published: April 2022
    Type: Resource Page
  3. The COVID-19 Maternal Immunization Resource Library is a one-stop information hub linking to global and country-specific research, guidance, tools, publications, and other resources related to COVID-19 vaccines and pregnancy and/or breastfeeding. The tool is designed to support decision-makers, implementers, funders, advocates, and others working to advance COVID-19 maternal immunization by connecting them to the latest information on research, safety registries, vaccine safety and acceptance, pregnancy outcomes, and other topics. Information will be useful for stakeholders across vaccine; maternal, newborn, and child health; and other public health fields.
    Published: April 2022
    Type: Resource Page
  4. This is a simple, Excel-based tool for assessing and comparing costs of human papillomavirus (HPV) vaccination programs annually and for a period of 10 years with HPV vaccine products available in the global market. It aims to help country-level policymakers compare products and estimate vaccination program costs for different HPV vaccines, exploring multiple vaccine options at a time. The tool can be used by decision-makers, implementers, technical partners, and others in any country, whether or not the country is eligible for co-funding from Gavi, the Vaccine Alliance. Estimates of vaccine cost (i.e., vaccine and supplies procurement and international shipping) and vaccination program costs (i.e., vaccine cost and cost of delivery) are calculated separately, based on user inputs, for two perspectives: (1) the country perspective and (2) the combined country and Gavi perspective (only relevant for Gavi-eligible countries). The tool also calculates the estimated vaccine dose and cold chain volume requirements, which can support operational planning and logistics.It is important to note that cost is only one consideration when selecting an HPV vaccine product, and users involved in decision-making around new vaccine introduction or product selection should always consider other dimensions as well. This model is meant to provide insights into the potential costs of alternative product choices and should not replace detailed budget planning once a product has been selected.A user guide is included in the file on a tab labeled “READ ME FIRST” which provides detailed instructions on how to use the tool and interpret the results. The tool is available to download in multiple languages below. For questions or support, contact PATH's Health Economics & Outcomes Research team: HEOR@path.org.
    Published: March 2022
    Type: Resource Page
  5. Global national HPV vaccine introduction maps.
    Published: March 2022
    Type: Resource Page
Load more